A more detailed discussion of safety and tolerability are provided later
Eligibility depends on factors such as medical history, current medications, laboratory findings, and overall health profile
Tirzepatide is a dual GIP/GLP-1 receptor agonist, a peptide that works on two key incretin pathways in the body to regulate blood sugar, reduce appetite, and promote meaningful weight loss
Patients can opt for cheaper versions of these drugs that are made by compounding pharmacies, but they can be unreliable and unsafe
The anesthetic cream needs to be in place for approximately 45 minutes to be maximally effective if it is prilocaine/lidocaine, like EMLA
Clinician-led GLP-1 weight loss you can trust